Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram Zuckerman

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
JACC. Heart Failure|March 15, 2025
An Innovative Program for Evidence Generation: HFC Perspective on the FDA Total Product Life Cycle Advisory ProgramMona Fiuzat, Kimberly Ferlin, Laura Gottschalk, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 1, 2023
The medical device development ecosystem: Current regulatory state and challenges for future development: A reviewDavid R Holmes, Andrew Farb, Nabil Dib, et al.
JACC. Cardiovascular Interventions|March 26, 2016
Clinical Perspective--Early Feasibility Device Medical Studies in the United States: Time for More Than Regulatory ReformDavid R Holmes, Jeff Shuren, Robert Califf, et al.
JACC. Heart Failure|February 4, 2017
FDA in the 21st Century: Focus on Tobacco Policies and Heart Failure PreventionMona Fiuzat, Tamar S Nordenberg, Mitchell Zeller, et al.
Journal of the American College of Cardiology|October 22, 2016
Overcoming the Challenges of Conducting Early Feasibility Studies of Medical Devices in the United StatesDavid R Holmes, Robert Califf, Andrew Farb, et al.
Circulation. Cardiovascular Quality and Outcomes|June 14, 2019
Integrating Quality of Life and Survival Outcomes in Cardiovascular Clinical TrialsJacob V Spertus, Laura A Hatfield, David J Cohen, et al.
JACC. Cardiovascular Interventions|November 10, 2018
The 21st Century Cures Act and Early Feasibility Studies for Cardiovascular Devices: What Have We Learned, Where Do We Need to Go?David R Holmes, Robert Hance, Tamara S Syrek Jensen, et al.
JAMA Cardiology|June 21, 2023
Comparative Effectiveness of Percutaneous Microaxial Left Ventricular Assist Device vs Intra-Aortic Balloon Pump or No Mechanical Circulatory Support in Patients With Cardiogenic ShockZaid I Almarzooq, Yang Song, Issa J Dahabreh, et al.
European Heart Journal|June 14, 2018
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus DocumentHector M Garcia-Garcia, Eugène P McFadden, Andrew Farb, et al.
Journal of the American College of Cardiology|February 2, 2018
Improving Heart Failure Therapeutics Development in the United States: The Heart Failure CollaboratoryChristopher M O'Connor, Mitchell A Psotka, Mona Fiuzat, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
JACC. Heart Failure|March 15, 2025
An Innovative Program for Evidence Generation: HFC Perspective on the FDA Total Product Life Cycle Advisory ProgramMona Fiuzat, Kimberly Ferlin, Laura Gottschalk, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 1, 2023
The medical device development ecosystem: Current regulatory state and challenges for future development: A reviewDavid R Holmes, Andrew Farb, Nabil Dib, et al.
JACC. Cardiovascular Interventions|March 26, 2016
Clinical Perspective--Early Feasibility Device Medical Studies in the United States: Time for More Than Regulatory ReformDavid R Holmes, Jeff Shuren, Robert Califf, et al.
JACC. Heart Failure|February 4, 2017
FDA in the 21st Century: Focus on Tobacco Policies and Heart Failure PreventionMona Fiuzat, Tamar S Nordenberg, Mitchell Zeller, et al.
Journal of the American College of Cardiology|October 22, 2016
Overcoming the Challenges of Conducting Early Feasibility Studies of Medical Devices in the United StatesDavid R Holmes, Robert Califf, Andrew Farb, et al.
Circulation. Cardiovascular Quality and Outcomes|June 14, 2019
Integrating Quality of Life and Survival Outcomes in Cardiovascular Clinical TrialsJacob V Spertus, Laura A Hatfield, David J Cohen, et al.
JACC. Cardiovascular Interventions|November 10, 2018
The 21st Century Cures Act and Early Feasibility Studies for Cardiovascular Devices: What Have We Learned, Where Do We Need to Go?David R Holmes, Robert Hance, Tamara S Syrek Jensen, et al.
JAMA Cardiology|June 21, 2023
Comparative Effectiveness of Percutaneous Microaxial Left Ventricular Assist Device vs Intra-Aortic Balloon Pump or No Mechanical Circulatory Support in Patients With Cardiogenic ShockZaid I Almarzooq, Yang Song, Issa J Dahabreh, et al.
European Heart Journal|June 14, 2018
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus DocumentHector M Garcia-Garcia, Eugène P McFadden, Andrew Farb, et al.
Journal of the American College of Cardiology|February 2, 2018
Improving Heart Failure Therapeutics Development in the United States: The Heart Failure CollaboratoryChristopher M O'Connor, Mitchell A Psotka, Mona Fiuzat, et al.
Pageof 4